Subcutaneous injection (most common): Injection sites: Abdomen (2 inches from the navel, any direction) Upper thighs (front or outer) Upper arms (outer aspect, if administered by an assistant) For localized treatment: near the injury site (within 23 inches) Procedure: Clean the injection site with an alcohol swab Let the alcohol dry completely Pinch the skin to create a fold of subcutaneous tissue Insert the needle at a 45-degree angle Inject slowly over 510 seconds Withdraw the needle smoothly Apply gentle pressure if needed (do not rub) Intramuscular injection (alternative): Injection sites: Deltoid (shoulder) Vastus lateralis (outer thigh) Gluteus medius (upper outer buttock) Procedure: Clean the site thoroughly Insert the needle at a 90-degree angle Aspirate slightly to confirm you are not in a blood vessel Inject slowly and steadily Withdraw the needle and apply pressure Dosing Frequency and Timing Frequency depends on research goals and injury characteristics
Safety is dominated by transient gastrointestinal events, with rare but serious risks of pathogen or antimicrobial-resistant organism transmission necessitating rigorous donor screening, validated manufacturing, traceability, and post-procedure surveillance under regulated protocols [256, 257]
Plasma GHK is bound to a fraction of albumin and is released by proteolysis
Adults 18+, take up to 2 tablespoons (30 mL) daily or as recommended by a physician or healthcare professional
Urinary Tract Infections (UTIs) People can be more likely to get infections in their urinary system
